Literature DB >> 429542

Selective and differential medium for isolation of Clostridium difficile.

W L George, V L Sutter, D Citron, S M Finegold.   

Abstract

Clostridium difficile is a recognized cause of pseudomembranous (antimicrobial agent-associated) colitis and may be one of the causes of antimicrobial agent-induced diarrhea. A selective and differential agar medium that contains cycloserine, cefoxitin, fructose, and egg yolk (CCFA) was developed to facilitate the isolation of C. difficile from fecal specimens. Quantitative cultures of 16 stock strains of C. difficile on this medium (and on a medium containing cycloserine, fructose, and egg yolk) yielded counts equivalent to those obtained on blood agar; other media selective for clostridia, including Clostrisel agar, reinforced clostridial agar plus 0.2% para-cresol, and egg yolk-neomycin agar (the latter was inoculated with cultures subjected to prior heat shocking), were also tested and found to be inhibitory to the growth of C. difficile. Of 28 fecal or colostomy effluent specimens cultured on the above media, 14 yielded C. difficile. CCFA was found to be the most sensitive and selective of these media for the recovery of C. difficile. Colonies of C. difficile growing on CCFA had distinctive morphological and fluorescent properties which were sufficient for presumptive identification. CCFA should provide a rapid method for the screening of fecal specimens from patients with antimicrobial agent-associated diarrhea or colitis for C. difficile.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429542      PMCID: PMC272994          DOI: 10.1128/jcm.9.2.214-219.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Clostridium difficile: isolation and characteristics.

Authors:  S Hafiz; C L Oakley
Journal:  J Med Microbiol       Date:  1976-05       Impact factor: 2.472

2.  Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage.

Authors:  L Katz; J T LaMont; J S Trier; E B Sonnenblick; S W Rothman; S A Broitman; S Rieth
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

3.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.

Authors:  J G Bartlett; A B Onderdonk; R L Cisneros; D L Kasper
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

4.  Clindamycin-associated colitis. Review of the clinical spectrum of 47 cases.

Authors:  F J Tedesco
Journal:  Am J Dig Dis       Date:  1976-01

5.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

6.  Evaluation and modifications of media for enumeration of Clostridium perfringens.

Authors:  A H Hauschild; R Hilsheimer
Journal:  Appl Microbiol       Date:  1974-01

7.  Aetiology of antimicrobial-agent-associated colitis.

Authors:  W L George; V L Sutter; E J Goldstein; S L Ludwig; S M Finegold
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

8.  Clostridium defficiel in the urogenital tract of males and females.

Authors:  S Hafiz; M G McEntegart; R S Morton; S A Waitkins
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

  8 in total
  197 in total

Review 1.  Clostridium difficile testing: after 20 years, still challenging.

Authors:  Tracy D Wilkins; David M Lyerly
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

2.  Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A.

Authors:  S P Borriello; T Vale; J S Brazier; S Hyde; E Chippeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

3.  Evaluation of a new commercial Clostridium difficile toxin A enzyme immunoassay using diarrhoeal stools.

Authors:  M Delmée; T Mackey; A Hamitou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

4.  The development of bacterial flora of premature neonates.

Authors:  V O Rotimi; S A Olowe; I Ahmed
Journal:  J Hyg (Lond)       Date:  1985-06

5.  Effective and reduced-cost modified selective medium for isolation of Clostridium difficile.

Authors:  Michelle M Nerandzic; Curtis J Donskey
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

6.  Evaluation of the 24-h API 20A anaerobe system for identification of Clostridium difficile.

Authors:  M E Gresser; C J Shanholtzer; D N Gerding; C R Garrett; L R Peterson
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

7.  Aging Dampens the Intestinal Innate Immune Response during Severe Clostridioides difficile Infection and Is Associated with Altered Cytokine Levels and Granulocyte Mobilization.

Authors:  Lisa Abernathy-Close; Michael G Dieterle; Kimberly C Vendrov; Ingrid L Bergin; Krishna Rao; Vincent B Young
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

8.  Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.

Authors:  K A Stellrecht; A A Espino; V P Maceira; S M Nattanmai; S A Butt; D Wroblewski; G E Hannett; K A Musser
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

9.  Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis.

Authors:  S W Rothman
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

10.  Prairie dog model for antimicrobial agent-induced Clostridium difficile diarrhea.

Authors:  E L Muller; H A Pitt; W L George
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.